Active Ingredient: ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Proprietary Name: TREZIX
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 320.5MG;30MG;16MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A204785
Product Number: 001
Approval Date: Nov 26, 2014
Applicant Holder Full Name: XSPIRE PHARMA
Marketing Status:
Prescription
Patent and Exclusivity Information